Inflammation, immunity, and Alzheimer's disease

CNS and Neurological Disorders - Drug Targets

Volumn 9, Issue 2, 2010, Pages 129-131

  Town, Terrence ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; FLAVONOID; GAMMA SECRETASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN 1;

ALZHEIMER DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOTHERAPY; INFLAMMATION; MICROGLIA; MONONUCLEAR PHAGOCYTE; PROPHYLAXIS; REVIEW;

EID: 77949911603     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152710791012008     Document Type: Review

References (11)

1. Selkoe, D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 2001, 81, 741-766.
2. Alzheimer, A.; Stelzmann, R.A.; Schnitzlein, H.N.; Murtagh, F.R. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin. Anat., 1995, 8, 429-431.
3. Szekely, C.A.; Zandi, P.P. Non-Steroidal Anti-Inflammatory Drugs and Alzheimer's Disease: The Epidemiological Evidence. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 132-139.
4. Cole, G.M.; Frautschy, S.A. Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 140-148.
5. Giunta, B.; Rezai-Zadeh, K.; Tan, J. Impact of the CD40-CD40L dyad in Alzheimer's Disease. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 149-155.
6. Mandrekar, S.; Landreth, G.E. Microglia and Inflammation in Alzheimer's Disease. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 156-167.
7. Hickman, S.E.; El Khoury, J. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 168-173.
8. Colton, C.A.; Wilcock, D.M. Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 174-191.
9. Fiala, M. Re-balancing of inflammation and Aβ immunity as a therapeutic for Alzheimer's disease-view from the bedside. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 192-196.
10. Fu, H.J.; Liu, B.; Frost, J.L.; Lemere, C.A. Amyloid-b Immunotherapy for Alzheimer's Disease. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 197-206.
11. Cribbs, D.H. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 207-216.